Position in CTMX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$70,500
-$3,740,764 QoQ
Shares Held
15,000
-98.3% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#146
of 178 holders
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CTMX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BOOTHBAY FUND MANAGEMENT, LLC holds $541,089,850 across 142 Biotechnology names. CTMX ranks #128 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
472,961 | $52,664,207 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
438,595 | $42,653,363 | |
| 3 | EXEL |
Exelixis, Inc.
|
803,866 | $34,477,812 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
522,019 | $30,334,524 | |
| 5 | MLYS |
Mineralys Therapeutics, Inc.
|
1,001,728 | $27,136,811 | |
| 6 | TERN |
Terns Pharmaceuticals, Inc.
|
486,170 | $25,630,882 | |
| 7 | CGEM |
Cullinan Therapeutics, Inc.
|
1,112,803 | $15,812,930 | |
| 8 | XENE |
Xenon Pharmaceuticals Inc.
|
270,412 | $15,724,457 |
All Filings in CTMX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $70,500 | 15,000 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $3,811,264 | 894,663 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $3,946,211 | 1,237,057 | Shares | Other | 2025-11-14 | |
| 2022-06-30 | $36,698 | 20,054 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $34,979 | 13,101 | Shares | Other | 2022-05-16 | |
| 2021-06-30 | $96,102 | 15,182 | Shares | Other | 2021-08-17 | |
| 2021-03-31 | $736,545 | 95,284 | Shares | Other | 2021-05-17 | |
| 2020-06-30 | $121,576 | 14,595 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $106,613 | 13,900 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||